Is there clinical evidence for aminoglycoside activity against SARS-CoV-2?

Aminoglycosides have been reported to reduce viral load of BVDV, HCV, DENV 1-4, and SARS-CoV-2 in vitro [1,2] and HSV-2, ZIKV, and influenza A in mice [3]. Based on this, is there any ongoing...

20 November 2020 4,635 9 View